Argus upgraded Solventum (SOLV) to Buy from Hold with a $90 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Hold Rating Maintained for Solventum Corporation Amid Strategic P&F Business Transaction Adjustments
- Solventum Amends Acquisition Deal with Thermo Fisher
- Solventum initiated with a Sector Weight at KeyBanc
- Solventum upgraded to Overweight from Neutral at Piper Sandler
- Promising Growth and Strategic Flexibility: A Buy Recommendation for Solventum Corporation